Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gene Therapeutics & RNAiGenome-based Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1646767

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1646767

Epigenetics

PUBLISHED:
PAGES: 427 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Epigenetics Market to Reach US$5.5 Billion by 2030

The global market for Epigenetics estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Epigenetics Reagents segment is estimated at 18.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$641.1 Million While China is Forecast to Grow at 19.4% CAGR

The Epigenetics market in the U.S. is estimated at US$641.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$549.7 Million by the year 2030 trailing a CAGR of 19.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 17.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.2% CAGR.

Global Epigenetics Market - Key Trends & Drivers Summarized

What Is Epigenetics and Why Is It Transformative for Modern Medicine?

Epigenetics is the study of changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes are influenced by environmental factors, lifestyle, and cellular signals and are mediated by mechanisms such as DNA methylation, histone modification, and non-coding RNA interactions. Epigenetics plays a crucial role in regulating biological processes, including development, aging, and disease progression, making it a transformative area of research and application in modern medicine.

The transformative potential of epigenetics lies in its ability to offer insights into how environmental factors and lifestyle choices affect gene expression and health outcomes. Epigenetic modifications are reversible, unlike genetic mutations, making them an attractive target for therapeutic intervention. For example, epigenetic therapies, such as histone deacetylase (HDAC) inhibitors and DNA methyltransferase inhibitors, are being developed to treat cancers, neurodegenerative disorders, and metabolic diseases. By understanding and targeting epigenetic mechanisms, researchers can develop personalized therapies that address the root causes of diseases, paving the way for precision medicine.

Additionally, epigenetics has a profound impact on diagnostics and drug development. Epigenetic biomarkers are increasingly being used to identify disease states, predict disease progression, and monitor treatment efficacy. These biomarkers, such as specific methylation patterns, enable early detection and non-invasive diagnostic methods for conditions like cancer. In drug development, epigenetic screening allows researchers to identify novel drug targets and optimize therapeutic strategies, accelerating innovation and improving patient outcomes. As a bridge between genetics and environment, epigenetics is central to advancing our understanding of health and disease and revolutionizing the future of medicine.

How Are Technological Advancements and Industry Demands Shaping the Epigenetics Market?

Technological advancements in sequencing, imaging, and computational tools are driving the epigenetics market by enabling more precise, high-throughput, and scalable research. Next-generation sequencing (NGS) technologies, such as whole-genome bisulfite sequencing and ChIP-sequencing, have revolutionized the study of epigenetics by allowing researchers to map DNA methylation and histone modifications across the genome. These tools provide unprecedented resolution and accuracy, enabling a deeper understanding of how epigenetic changes influence gene regulation and disease processes. Advances in single-cell sequencing further enhance these capabilities by allowing researchers to analyze epigenetic modifications at the single-cell level, uncovering cellular heterogeneity in tissues and tumors.

High-resolution imaging techniques, such as super-resolution microscopy and advanced fluorescence imaging, are also transforming epigenetics research by visualizing chromatin dynamics and histone modifications in real time. These tools allow scientists to study the spatial organization of epigenetic marks and their impact on gene expression within living cells, providing insights into the dynamic nature of epigenetic regulation. Combined with computational algorithms and AI-powered analytics, imaging and sequencing data can be integrated to generate comprehensive epigenetic maps, facilitating more accurate predictions of gene behavior and disease outcomes.

The increasing demand for personalized medicine is further shaping the epigenetics market as industries seek innovative ways to develop targeted therapies and diagnostics. Epigenetics provides a framework for understanding individual variations in gene expression and disease susceptibility, enabling the development of tailored interventions. For example, precision oncology leverages epigenetic biomarkers to identify tumor-specific modifications and guide treatment decisions. Similarly, epigenetic data informs the design of personalized lifestyle and nutritional recommendations, supporting preventive healthcare. Together, advancements in sequencing, imaging, and personalized medicine are driving the growth of the epigenetics market, making it a cornerstone of modern biomedical research and therapeutic innovation.

Where Is Epigenetics Making the Greatest Impact Across Industry Segments?

Epigenetics is making a significant impact across various industry segments, including oncology, neuroscience, regenerative medicine, and agriculture, each benefiting from enhanced understanding, diagnostics, and therapeutic approaches. In oncology, epigenetics is revolutionizing cancer research and treatment by uncovering the epigenetic mechanisms underlying tumor growth, metastasis, and resistance to therapy. Epigenetic therapies, such as HDAC inhibitors and DNA methyltransferase inhibitors, are being used to reactivate tumor suppressor genes and sensitize cancer cells to chemotherapy. Additionally, epigenetic biomarkers enable early cancer detection and personalized treatment strategies, improving patient outcomes and reducing the burden of disease.

In neuroscience, epigenetics is providing critical insights into the molecular mechanisms of neurodevelopmental and neurodegenerative disorders, such as Alzheimer’s disease, autism, and depression. Epigenetic modifications, including histone acetylation and DNA methylation, play a central role in brain plasticity and memory formation. By targeting these modifications, researchers are developing novel therapies to treat neurological conditions and restore cognitive function. Epigenetics also sheds light on the interplay between genetics and environmental factors in mental health, enabling the development of holistic approaches to prevention and treatment.

In regenerative medicine, epigenetics is driving advances in stem cell research and tissue engineering. Epigenetic reprogramming techniques, such as the induction of pluripotency, allow scientists to generate patient-specific stem cells for use in regenerative therapies. These stem cells can be differentiated into various cell types by modulating their epigenetic states, enabling the development of personalized treatments for conditions like diabetes, cardiovascular disease, and spinal cord injuries. Epigenetics also plays a role in enhancing the efficiency of tissue regeneration and improving the stability of engineered tissues, making it integral to the future of regenerative medicine.

In agriculture, epigenetics is being used to improve crop resilience, yield, and quality by understanding how plants respond to environmental stressors, such as drought, heat, and pathogens. Epigenetic modifications in plants regulate gene expression in response to changing conditions, enabling scientists to develop stress-tolerant crop varieties without genetic modification. These epigenetic approaches contribute to sustainable agriculture by reducing reliance on chemical inputs and enhancing food security in the face of climate change. Across these segments, epigenetics supports innovation, precision, and sustainability, highlighting its broad applications and transformative potential.

What Are the Key Drivers Fueling Growth in the Epigenetics Market?

The growth in the epigenetics market is driven by several key factors, including rising prevalence of chronic and complex diseases, increasing demand for personalized medicine, and advancements in research technologies. The rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurodegenerative disorders, is a primary driver as these conditions are often influenced by epigenetic modifications. Epigenetics provides insights into disease mechanisms and offers therapeutic targets for conditions with limited treatment options, driving investment in epigenetic research and drug development.

The increasing demand for personalized medicine is another significant driver, as healthcare shifts toward tailored approaches that address individual variations in disease susceptibility and response to treatment. Epigenetic biomarkers enable stratification of patient populations and guide the development of targeted therapies, particularly in oncology and rare genetic disorders. The ability to use epigenetic data to predict treatment efficacy and monitor disease progression enhances the precision and effectiveness of medical interventions, aligning with the broader trend of precision healthcare.

Advancements in research technologies, including next-generation sequencing, single-cell analysis, and bioinformatics, are also propelling the market. These technologies provide the tools needed to explore the complex and dynamic nature of epigenetic regulation, enabling breakthroughs in understanding and application. The integration of AI and machine learning further accelerates discoveries by identifying patterns and correlations in large epigenetic datasets. These technological advancements lower the cost and complexity of epigenetics research, making it more accessible to academic, clinical, and commercial entities.

Together, these drivers—disease prevalence, personalized medicine demand, and technological advancements—are fueling growth in the epigenetics market. As industries continue to leverage epigenetic insights to address unmet medical needs and innovate across sectors, epigenetics is poised to play a central role in shaping the future of healthcare, agriculture, and beyond.

SCOPE OF STUDY:

The report analyzes the Epigenetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes, Epigenetics Instruments & Consumables); Technology (DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology, Chromatin Structures Technology); Application (Oncology Application, Non-Oncology Application)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 95 Featured) -

  • Abnova Corporation
  • Active Motif, Inc.
  • biomodal Ltd.
  • Bio-Rad Laboratories, Inc.
  • BPS Bioscience, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • EpiCypher, Inc.
  • Epigentek Group Inc.
  • Fios Genomics Ltd.
  • Genomescan
  • Illumina, Inc.
  • Merck Millipore
  • New England Biolabs, Inc.
  • Novogene Co. Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • Qiagen, Inc.
  • Revvity, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation
Show more
Product Code: MCP-6259

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Human Quest for Supremacy Over Diseases Sets the Tone for Growth of Epigenetics as a Transformative Force in Healthcare
    • EXHIBIT 1: Medical Research is Sacrosanct & So is Epigenetics' Role as a Catalyst for Health Transformation: Global Pharmaceutical Research and Development Spending (In US$ Billion) for Years 2025, 2027, 2029, and 2031
    • Economic Frontiers: Trends, Trials & Transformations
    • EXHIBIT 2: In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 3: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • EXHIBIT 4: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • Competition
    • EXHIBIT 5: Epigenetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 95 Players Worldwide in 2024 (E)
    • What is Epigenetics? A Technical Rumination
    • Influencer/Product/Technology Insights
    • Recent Market Activity
    • Innovations
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Diseases Sets the Stage for Growth of Epigenetics
    • EXHIBIT 6: As Disease Burden Rises So Does the Value of Epigenetics in Understanding Diseases & Developing Cutting Edge Therapies: Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
    • Growing Focus on Understanding Inflammatory Musculoskeletal Diseases Brings Epigenetics Into the Spotlight
    • EXHIBIT 7: Growing Burden of Musculoskeletal Disorders (MSDs) Pins Hope on Epigenetics for Solutions: Global Prevalence of MSDs (In Million) for Years 2024, 2030, 2040 and 2050
    • Exponential Rise in Cancer Pins Hope on Epigenetic Therapies
    • EXHIBIT 8: Rising Cancer Burden Exerts Pressure on Epigenetics to Move Swiftly from Laboratory Studies and Clinical Trials to Precision Medicine: Global Incidence of Cancer (In Million) for Years 2020, 2030 and 2040
    • The Shift Towards Personalized Medicine Expands The Role Of Epigenetics
    • EXHIBIT 9: As Personalized Medicine Gains Momentum, New Doors of Opportunities Open for Epigenome-Based Personalized Medicine: Global Market for Personalized Medicine (In US$ Billion) for Years 2025, 2027, 2029, 2031 and 2033
    • A New Era for Epigenetic Studies Open with the Entry of Artificial Intelligence
    • EXHIBIT 10: The Potential for Applying Artificial Intelligence to Epigenetics is Just Emerging Supported by Growing AI Spending: Global Spending on AI in Healthcare (In US$ Billion) for Years 2025, 2027, 2029, 2031, and 2033
    • Advancements in Epigenome Editing Drives Growth in the Market
    • Focus on Crop Improvement Amid Climate Change Drives Up the Value of Epigenetics in Agriculture
    • EXHIBIT 11: Inverse Relationship Between Rising Temperatures Due to Emissions Induced Climate Change & Crop Productivity Drives Interest in Epigenetics for Plant Breeding: Global CO2 Emissions (In Billion Metric Tons) for Years 1960, 1970, 1980, 1990, 2000, 2010, 2020, 2021, 2022, 2023 and 2024
    • Ethical Issues Continue to Surround the Field of Epigenetics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Epigenetics Market Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 4: World 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2019, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 7: World 11-Year Perspective for Epigenetics Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 10: World 11-Year Perspective for Epigenetics Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 13: World 11-Year Perspective for Epigenetics Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 16: World 11-Year Perspective for Epigenetics Instruments & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 19: World 11-Year Perspective for DNA Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 22: World 11-Year Perspective for Histone Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 25: World 11-Year Perspective for Histone Acetylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 28: World 11-Year Perspective for Large Non-Coding RNA Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 31: World 11-Year Perspective for MicroRNA Modification Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 34: World 11-Year Perspective for Chromatin Structures Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 37: World 11-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 40: World 11-Year Perspective for Non-Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 41: USA Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 43: USA 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 46: USA 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 49: USA 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 52: Canada 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 55: Canada 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 58: Canada 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • JAPAN
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 61: Japan 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 64: Japan 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 67: Japan 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CHINA
    • TABLE 68: China Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 70: China 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 73: China 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 76: China 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • EUROPE
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 79: Europe 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2019, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 82: Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 85: Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 88: Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • FRANCE
    • TABLE 89: France Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 91: France 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 94: France 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 97: France 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • GERMANY
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 100: Germany 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 103: Germany 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 106: Germany 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 109: Italy 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 112: Italy 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 115: Italy 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 116: UK Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 118: UK 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 121: UK 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 124: UK 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ASIA-PACIFIC
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 145: Rest of World 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 148: Rest of World 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 151: Rest of World 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!